Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 4/20 | 0.46 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.44 |
| ▸ | FABP7 | O15540 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | MDM4 | O15151 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 2/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28036073 | 1.00 | KMT2A (0.48) | KMT2ATLR2FABP5FABP7HDAC1 | |
| SCHEMBL524545 | 1.00 | KMT2A (0.48) | KMT2ATLR2FABP5FABP7HDAC1 | |
| SCHEMBL524835 | 1.00 | KMT2A (0.48) | KMT2ATLR2FABP5FABP7HDAC1 | |
| SCHEMBL3426738 | 1.00 | KMT2A (0.48) | KMT2ATLR2FABP5FABP7HDAC1 | |
| SCHEMBL3976225 | 1.00 | KMT2A (0.48) | KMT2ATLR2FABP5FABP7HDAC1 | |
| SCHEMBL25144 | 0.99 | KMT2A (0.49) | KMT2ATLR2FABP5FABP7HDAC1 | |
| SCHEMBL97613 | 0.95 | KMT2A (0.50) | KMT2ATLR2FABP5FABP7CA1 | |
| Succinic Acid SCHEMBL28760118 | 0.94 | KMT2A (0.50) | KMT2ATLR2FABP5FABP7HDAC1 | |
| Tetrahydrofuran SCHEMBL28301142 | 0.91 | KMT2A (0.43) | KMT2ATLR2FABP5FABP7HDAC1 | |
| SCHEMBL31658990 | 0.90 | KMT2A (0.44) | KMT2ATLR2FABP5FABP7HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2598157-B1 | CYCLIC PEPTIDES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF THE PLATELET ADHESION | SANOFI SA (FR) | 2016-10-12 | — | — | EP | disclosed |
| US-9073975-B2 | Cyclic peptides, their preparation and their use as inhibitors of the platelet adhesion | SANOFI (FR) | 2015-07-07 | — | — | US | disclosed |
| US-20140011734-A1 | CYCLIC PEPTIDES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF THE PLATELET ADHESION | SANOFI (FR) | 2014-01-09 | — | — | US | disclosed |
| EP-2598157-A1 | CYCLIC PEPTIDES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF THE PLATELET ADHESION | SANOFI (FR) | 2013-06-05 | — | — | EP | disclosed |
| WO-2012013709-A1 | CYCLIC PEPTIDES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF THE PLATELET ADHESION | SANOFI (FR) | 2012-02-02 | — | — | WO | disclosed |
| US-20050096456-A1 | Compounds comprising pseudo-amino acids | ADPRO TECH LIMITED (GB) | 2005-05-05 | — | — | US | disclosed |
| EP-1487860-A1 | COMPOUNDS COMPRISING PSEUDO-AMINO ACIDS | AdProTech Limited (GB) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003080650-A1 | COMPOUNDS COMPRISING PSEUDO-AMINO ACIDS | ADPROTECH LIMITED (GB) | 2003-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140011734-A1 | CYCLIC PEPTIDES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF THE PLATELET ADHESION | F12, F11, F13B | KMT2A 4818/4885TLR2 3514/4885FABP5 2630/4885 |
| US-20050096456-A1 | Compounds comprising pseudo-amino acids | QPCTL, LNPEP, QPCT | KMT2A 1913/4885TLR2 3811/4885FABP5 1589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.